Lilly's Weight-Loss Pill Data Achieves "Best-Case Scenario", Sending Rival Novo Shares Into Abyss

El Lilly’s weight loss pill data blows away expectations, sending shares soaring & rival Novo Nordisk’s to an all-time low. The results could change the face of the weight loss landscape, empowering a new generation of obesity fighters. #WeightLoss #NovoNordisk


0

Leave a Reply

Your email address will not be published. Required fields are marked *